Corporate Information

Message from our President

New Possibilities Through Flexible Thinking

The environment surrounding pharmaceutical companies is changing rapidly.
While interest in the advancement of innovative medical technology is growing due to the heightened awareness of people's health, expectations are rising for medical care that everyone can receive with peace of mind in a society where the birthrate is declining and the population is aging.
In Japan, while curbing the growth of soaring medical and drug costs, reforms to create a sustainable future are underway. In addition, many people in emerging countries, including the Asian region, are seeking safe and high-quality pharmaceuticals.
At Kokando Pharmaceutical, we place the utmost importance on creating high-quality, heartfelt products that patients can use with peace of mind, based on solid knowledge and experience.
We will contribute to people's health by always looking ahead of the times and engaging in research and development with a youthful spirit and a willingness to take on new challenges. Therefore, based on our management philosophy, we will actively invest in research and development, production facilities, and human resource development. Utilizing digital transformation, we strive to develop and produce pharmaceuticals with excellent quality and safety, backed by a strong commitment to ethical and moral standards.

Safe, high-quality products at affordable prices

What is expected of generic manufacturers. These are stable supply, quality assurance, reliable information provision, and the expansion of generic drugs to the world.
With the advent of aging societies not only in developed countries but also in emerging countries, drug prices will be restrained, and the overseas market for generic drugs will grow significantly.
At Kokando Pharmaceutical, we promote efficiency through thorough quality control and strict manufacturing control, and provide patients with safe, high-quality products at affordable prices.
In addition to maintaining and improving the quality assurance system established based on the quality manual, we conduct thorough quality control at all stages, from raw materials to final products, with a high level of control awareness regarding the established manufacturing and quality standards.
At Kokando Pharmaceutical, we have introduced state-of-the-art manufacturing equipment to improve productivity, while promoting the computerization of manufacturing processes and the standardization of related operational processes to produce safe, high-quality products.

Healthier and more beautiful lives - our mission!!

We hope to be of service to people's health and lives by understanding people's enduring needs and the new needs that arise with the times.
With ambition and passion, we strive to improve our technical capabilities with flexible thinking, and we will do our best to be of use to everyone.
In addition to the domestic market, we will also expand into overseas markets, mainly in Southeast Asia, with OTC drugs and generic drugs as our pillars.
We appreciate your continued understanding and support.

President COO

FUJIWARA Hiroaki

Company Profile

Company Name
Kokando Pharmaceutical Co., Ltd.
Established Date
February 1st, 1980
Locations
  • Head Office2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803
  • R&D Site2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803
  • Tokyo Office1-7-1 Yurakucho, Chiyoda-ku, Tokyo, Japan 100-0006
  • Amagasaki plant2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803
  • Sanda plant21-1 Techno-park, Sanda, Hyogo, Japan 669-1339
  • Chairman CEOFUJIWARA Kunio
  • President COOFUJIWARA Hiroaki
Capital
350 Million Yen
Sales Proceeds
Sales 8740 Million Yen (for the year ended in June 2025)
Business Outline
Manufacturing and Sales of Medicines
Number of Employees
237 (as of June 30, 2025)
Affiliated Companies
Kokando Medicine Co., Ltd.

  • Head office1-7-1 Yurakucho,Chiyoda-Ku,Tokyo,Japan 100-0006
  • Tokyo・Nagoya・Amagasaki

History

1980s

  • 1980

    Company founded

  • 1981

    “REISHI”, as health food containing (-2019) activated

  • 1982

    Manufacturing site in Amagasaki completed

  • 1983

    Manufacturing and marketing of pharmaceutical drugs started

  • 1985

    Tokyo Office opened

  • 1986

    “SENNA Tablets” launched

  • 1989

    “NEO CALCIUM Tablets” launched

1990s

  • 1991

    “BEAULUCK”, for constipation, launched

    BEAULUCK
  • 1992

    “NATURAL VITAMIN E” (-2017) and “VITAMIN C Tablets” (-2013) launched

  • 1993

    The second manufacturing site in Amagasaki relocated (merged later)

  • 1994

    “VITAMIN BB” (-2008) launched

  • 1996

    “KOKANDO KAMPO BENPIYAKU”, for constipation, and “NEO VITAMIN EX” (-2012) launched

  • 1997

    The first manufacturing site in Amagasaki expanded and merged as Amagasaki Plant
    “NODONI TROCHE” launched

  • 1998

    “VITAMIN EC-L Tablets” launched

2000s

  • 2000

    Nagoya Office opened
    “CALCIUM-L Tablets” launched, “SOUGOUKANBOUYAKU”, a cold remedy, (-2017) launched

  • 2002

    “NEOVITA C Tablets” and “TOTAL COLD MEDICINE A” launched

  • 2003

    Several pharmaceutical drugs (analgesics etc.) launched
    “CHONDRO POWER EX Tablets”, for arthralgia, and “BIENYAKU”, for rhinitis, “TOTAL COLD MEDICINE” launched

    BIENYAKU
  • 2005

    Kokando Medicine Co., Ltd. established
    “BEAULUCK SOFT”, for constipation, launched

  • 2007

    Manufacturing site in Sanda completed

    “NEOVITA WHITE PLUS” (-2018) launched

  • 2008

    Head office relocated

  • 2009

    “NEW NEOVITAMIN EX”, “VITAMIN BB PLUS” and “ADAM A Tablets”, an antipyretic analgesic, launched

2010s

  • 2010

    “RIPOSMIN”, for insomnia, launched

  • 2011

    “NORIMONOYOINOKUSURI”, for motion sickness, and “ANTI ALLERGIC Tablets” launched

  • 2012

    “JIYOUKYOUSOUYAKU α”, as health food for nourishment and tonicity, and “GERIDOME Tablets”, for acute diarrhea or diarrhea with pain, launched
    Tokyo Office relocated

  • 2013

    “Famotidine Tablets” launched

  • 2014

    “LOXOPROFEN Tablets” launched

    LOXOPROFEN Tablets
  • 2016

    “ALLERBI” launched

    ALLERBI
  • 2017

    “HEPAFIT” launched

  • 2018

    “NEOVITA WHITE C PLUS” launched

2020s

  • 2021

    “ACETAMINOPHEN Tablets A” launched

    ACETAMINOPHEN Tablets A

    Completion of New Building at the Sanda Plant

    Sanda plant
  • 2023

    “Shakuyakukanzoto Extract granules” launched

Office

  • View larger map

    Head Office

    2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803
  • View larger map

    Sanda plant

    21-1 Techno-park, Sanda, Hyogo, Japan 669-1339

  • Amagasaki plant

    2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803